Botulax

Buy Botulax (Letybo) Online — Wholesale Botulinum Toxin for US Licensed Practitioners

Beauty Dermal offers Botulax (Letybo) — the FDA-approved Korean botulinum toxin type A manufactured by Hugel Inc. — at competitive wholesale prices for licensed medical aesthetics professionals across the United States. Choose from 100U and 200U vials, shipped cold-chain secured with same-week dispatch and verified origination from authorized supply channels.

What Is Botulax and How Does It Relate to Letybo?

Botulax is the South Korean brand name for letibotulinumtoxinA-wlbg, a purified botulinum toxin type A product developed by Hugel Inc. in 2010. In the US market, the same product is sold under the FDA-registered trade name Letybo® — the formulation, active ingredient, manufacturing site, and clinical profile are identical. Letybo received FDA approval for the temporary improvement of moderate-to-severe glabellar lines in adults following Phase 1–3 clinical trials across more than 1,000 US and European participants. Both names refer to the same vial. When practitioners search for Botulax online, they are looking for Letybo — and vice versa.

Product Specifications

• Active ingredient: Clostridium Botulinum Toxin Type A (strain CBFC26)
• Excipients: Human serum albumin, sodium chloride (0.9 mg)
• Manufacturer: Hugel Inc., South Korea — KFDA & GMP certified
• Regulatory status: FDA-approved (Letybo®); KFDA-approved; approved in EU, Canada, China
• Available presentations: 100U / 200U lyophilized powder vials
• Reconstitution: Sterile non-bacteriostatic 0.9% NaCl (normal saline)
• Post-reconstitution stability: Use within 24 hours; store at 2–8°C
• Unopened storage: 2–8°C, hermetically sealed; 36-month shelf life
• Appearance: White lyophilized powder → colorless transparent solution after reconstitution

Which Vial Size Is Right for Your Practice?

Botulax is available in three unit configurations, allowing practices to optimize per-treatment cost based on patient volume and treatment protocols:

• Botulax 100U — the standard unit for single-session treatments, ideal for focused areas such as glabellar lines, crow’s feet, or brow lifts. Most commonly ordered for lower-volume or boutique aesthetic practices.
• Botulax 200U — suited for multi-area sessions or practices treating forehead, glabella, and periorbital regions within a single appointment. Reduces waste when split-vial protocols are clinically appropriate.

Clinical Applications of Botulax (Letybo)

As an acetylcholine release inhibitor and neuromuscular blocking agent, Botulax produces temporary, targeted muscle relaxation by disrupting neuromuscular conduction at the motor endplate. Licensed practitioners apply it across both cosmetic and therapeutic indications: Aesthetic applications:

• Glabellar lines (frown lines) — FDA-approved primary indication
• Horizontal forehead rhytids
• Crow’s feet (lateral periorbital lines)
• Brow lift and brow shaping
• Lip flip and perioral fine lines
• Platysmal bands (neck rejuvenation)
• Masseteric hypertrophy (jawline slimming)
• Calf reduction and body contouring

Therapeutic applications:

• Primary hyperhidrosis (axillary, palmar, plantar)
• Blepharospasm
• Chronic migraine prevention (off-label)
• Muscle spasticity management

Onset, Duration, and Clinical Expectations

Practitioners typically observe initial muscle relaxation within 2–3 days post-injection, with peak effect visible at 7–14 days. Duration of results ranges from 3 to 6 months depending on treatment area, injected dose, individual patient metabolism, and prior treatment history. Maintenance scheduling every 4–6 months over the first year is standard; some patients extend intervals to once or twice annually after sustained treatment.

Botulax vs. Botox, Dysport, and Nabota — What Practitioners Should Know

All four products are botulinum toxin type A preparations with comparable mechanisms of action. Key clinical and procurement differences:

• Unit non-interchangeability: Botulax (Letybo) units are calibrated to Hugel’s proprietary bioassay and are not clinically equivalent to units of Botox (Allergan), Dysport (Galderma), Xeomin (Merz), or Nabota (Daewoong). Always apply Hugel’s dosing guidelines when switching or combining.
• Onset: Botulax demonstrates a rapid onset of 2–3 days — comparable to Nabota and faster than some practitioners report with standard Botox in certain anatomical areas.
• Duration: 3–6 months; Botulax may offer slightly extended duration compared to Nabota (3–4 months) based on published comparative data.
• Cost efficiency: Korean botulinum toxins including Botulax offer significantly lower cost-per-unit versus Allergan Botox, without compromising GMP-certified manufacturing standards.
• Regulatory standing: Botulax (as Letybo) is among a small group of Korean neuromodulators with full FDA approval — alongside Nabota (Jeuveau®).

Post-Injection Practitioner Guidelines

• Advise patients to remain upright for at least 4 hours after injection
• No massage, rubbing, or pressure on treated areas for a minimum of 4 hours
• Avoid strenuous physical activity and alcohol for 24 hours post-treatment
• Caution with co-administration of aminoglycosides, anticholinergic agents, or other agents affecting neuromuscular transmission — may potentiate Botulax effects
• Not recommended for pregnant or lactating women, or patients with known hypersensitivity to any botulinum toxin preparation

Why Aesthetic Professionals Order Botulax from Beauty Dermal

• Licensed practitioners only — credential verification before every order
• Cold-chain guaranteed — refrigerated insulated packaging with sufficient coolant; overnight shipping available for temperature-sensitive delivery
• Wholesale volume pricing — tiered discounts for clinics ordering multiple vials or SKUs
• Authentic sourcing — products traceable to authorized Hugel distribution channels
• Fast US dispatch — orders fulfilled within 1–3 business days

FAQ

Is Botulax the same as Letybo?

Yes. Botulax (Korean market name) and Letybo (FDA-registered US trade name) are the same product made by the same manufacturer — Hugel Inc. The active ingredient, formulation, and clinical data are identical.

Is Letybo (Botulax) FDA-approved in the USA?

Yes. Letybo (letibotulinumtoxinA-wlbg) holds FDA approval for temporary improvement of moderate-to-severe glabellar lines in adults. It is one of only two Korean botulinum toxins with current FDA-approved status, alongside Nabota (Jeuveau®).

Can Botulax units be substituted 1:1 for Botox units?

No. The potency units of Botulax (Letybo) are specific to Hugel’s bioassay and are not interchangeable with Botox, Dysport, Xeomin, or any other botulinum toxin product. Practitioners should follow Hugel’s approved dosing guidelines when transitioning patients or designing treatment protocols.

How should Botulax be stored and how long does it last?

Unopened vials should be stored sealed at 2–8°C away from direct light. Shelf life is 36 months from manufacture date. Once reconstituted with sterile saline, use within 24 hours and keep refrigerated.

Who can purchase Botulax from Beauty Dermal?

Botulax (Letybo) is a prescription neuromodulator available exclusively to licensed medical professionals — physicians, nurse practitioners, PAs, and other qualified injectors. Beauty Dermal verifies licensure before processing orders. Not available to estheticians, cosmetologists, or unlicensed individuals.

Can Botulax be combined with dermal fillers?

Yes. Botulax is routinely used alongside hyaluronic acid dermal fillers in combined facial rejuvenation protocols. Neuromodulators address dynamic wrinkles caused by muscle movement, while fillers restore lost volume — the two modalities complement rather than interfere with each other.